PUBLISHER: TechNavio | PRODUCT CODE: 2055807
PUBLISHER: TechNavio | PRODUCT CODE: 2055807
Global Blood Glucose Monitoring Devices Market 2026-2030
The global blood glucose monitoring devices market is forecasted to grow by USD 10527 mn during 2025-2030, accelerating at a CAGR of 9.6% during the forecast period. The report on the global blood glucose monitoring devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating global prevalence of diabetes and geriatric demographics, technological advancements and shift toward continuous glucose monitoring systems, proliferation of digital health ecosystems and remote patient monitoring.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 9.1% |
| CAGR | 9.6% |
| Incremental Value | $10527 mn |
Technavio's global blood glucose monitoring devices market is segmented as below:
By End-User
- Hospitals
- Home care
- Diagnostic centers
By Product
- Self monitoring
- Continuous glucose monitoring devices
By Indication
- Type-2 diabetes population
- Type-1 diabetes population
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the expansion of over counter approvals and wellness consumer adoption as one of the prime reasons driving the global blood glucose monitoring devices market growth during the next few years. Also, integration of ai and predictive glucose analytics and growing demand for non-invasive technologies and extended-wear biosensors will lead to sizable demand in the market.
The report on the global blood glucose monitoring devices market covers the following areas:
- Global blood glucose monitoring devices market sizing
- Global blood glucose monitoring devices market forecast
- Global blood glucose monitoring devices market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global blood glucose monitoring devices market vendors that include A. Menarini Diagnostics S.r.l., Abbott Laboratories, ACON Laboratories Inc., Agamatrix Inc., Ascensia Diabetes Care, B.Braun SE, Bionime Corp., Dexcom Inc., EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., I SENS Inc., LifeScan IP Holdings LLC, Medtronic Plc, Nipro Medical Corp., Nova Biomedical Corp., Osang Healthcare Co. Ltd., Prodigy Diabetes Care LLC, Senseonics Holdings Inc., TaiDoc Technology Corp., Terumo Corp., Trivida Health Inc., WaveForm Technologies. Also, the global blood glucose monitoring devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Indication
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Blood Glucose Monitoring Devices Market 2020 - 2024
- Historic Market Size - Data Table on Global Blood Glucose Monitoring Devices Market 2020 - 2024 ($ million)
- 5.2 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.3 Product segment analysis 2020 - 2024
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
- 5.4 Indication segment analysis 2020 - 2024
- Historic Market Size - Indication Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global blood glucose monitoring devices market
- 6.2 Impact of geopolitical conflicts on global blood glucose monitoring devices market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by End-user
- 8.1 Market segments
- 8.2 Comparison by End-user
- 8.3 Hospitals - Market size and forecast 2025-2030
- 8.4 Home care - Market size and forecast 2025-2030
- 8.5 Diagnostic centers - Market size and forecast 2025-2030
- 8.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
9 Market Segmentation by Product
- 9.1 Market segments
- 9.2 Comparison by Product
- 9.3 Self monitoring - Market size and forecast 2025-2030
- 9.4 Continuous glucose monitoring devices - Market size and forecast 2025-2030
- 9.5 Market opportunity by Product
- Market opportunity by Product ($ million)
10 Market Segmentation by Indication
- 10.1 Market segments
- 10.2 Comparison by Indication
- 10.3 Type-2 diabetes population - Market size and forecast 2025-2030
- 10.4 Type-1 diabetes population - Market size and forecast 2025-2030
- 10.5 Market opportunity by Indication
- Market opportunity by Indication ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 India - Market size and forecast 2025-2030
- 12.5.3 Japan - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 Colombia - Market size and forecast 2025-2030
- 12.6.7 South Africa - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Escalating global prevalence of diabetes and geriatric demographics
- Technological advancements and shift toward continuous glucose monitoring systems
- Proliferation of digital health ecosystems and remote patient monitoring
- 13.2 Market challenges
- Stringent and evolving regulatory frameworks paired with product safety concerns
- Economic disparities and persisting affordability gap in emerging economies
- Cybersecurity vulnerabilities and interoperability friction in connected digital environments
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Expansion of over counter approvals and wellness consumer adoption
- Integration of AI and predictive glucose analytics
- Growing demand for non-invasive technologies and extended-wear biosensors
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 A. Menarini Diagnostics S.r.l.
- A. Menarini Diagnostics S.r.l. - Overview
- A. Menarini Diagnostics S.r.l. - Product / Service
- A. Menarini Diagnostics S.r.l. - Key offerings
- SWOT
- 15.5 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 15.6 ACON Laboratories Inc.
- ACON Laboratories Inc. - Overview
- ACON Laboratories Inc. - Product / Service
- ACON Laboratories Inc. - Key offerings
- SWOT
- 15.7 Agamatrix Inc.
- Agamatrix Inc. - Overview
- Agamatrix Inc. - Product / Service
- Agamatrix Inc. - Key offerings
- SWOT
- 15.8 B.Braun SE
- B.Braun SE - Overview
- B.Braun SE - Product / Service
- B.Braun SE - Key offerings
- SWOT
- 15.9 Bionime Corp.
- Bionime Corp. - Overview
- Bionime Corp. - Product / Service
- Bionime Corp. - Key offerings
- SWOT
- 15.10 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 15.11 LifeScan IP Holdings LLC
- LifeScan IP Holdings LLC - Overview
- LifeScan IP Holdings LLC - Product / Service
- LifeScan IP Holdings LLC - Key offerings
- SWOT
- 15.12 Medtronic Plc
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key news
- Medtronic Plc - Key offerings
- Medtronic Plc - Segment focus
- SWOT
- 15.13 Nipro Medical Corp.
- Nipro Medical Corp. - Overview
- Nipro Medical Corp. - Business segments
- Nipro Medical Corp. - Key offerings
- Nipro Medical Corp. - Segment focus
- SWOT
- 15.14 Nova Biomedical Corp.
- Nova Biomedical Corp. - Overview
- Nova Biomedical Corp. - Product / Service
- Nova Biomedical Corp. - Key offerings
- SWOT
- 15.15 Prodigy Diabetes Care LLC
- Prodigy Diabetes Care LLC - Overview
- Prodigy Diabetes Care LLC - Product / Service
- Prodigy Diabetes Care LLC - Key offerings
- SWOT
- 15.16 Senseonics Holdings Inc.
- Senseonics Holdings Inc. - Overview
- Senseonics Holdings Inc. - Product / Service
- Senseonics Holdings Inc. - Key offerings
- SWOT
- 15.17 TaiDoc Technology Corp.
- TaiDoc Technology Corp. - Overview
- TaiDoc Technology Corp. - Product / Service
- TaiDoc Technology Corp. - Key offerings
- SWOT
- 15.18 Terumo Corp.
- Terumo Corp. - Overview
- Terumo Corp. - Business segments
- Terumo Corp. - Key news
- Terumo Corp. - Key offerings
- Terumo Corp. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
